190A Chordia Therapeutics Inc.Chordia TherapeuticsTSE Growth / Pharmaceuticals
0 posts
Chordia Therapeutics Inc. stock rose on Nov 19: what happened
It closed at ¥45.0 on Nov 19 (+¥4.0, +9.76%), ranking #15 among the top gainers of all stocks on the Tokyo Stock Exchange.
No disclosures were found for this stock around that day. Share what you know in the posts below.
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
Chordia Therapeutics Inc. (190A) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Chordia Therapeutics Inc. (190A) Stock Price History
Chordia Therapeutics Inc. closed at ¥45.0 on Nov 19, 2026, −19.6% over 1 month, −55.4% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥80,357 today (−19.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −8.4%, while this stock moved −19.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 19 (Thu) | ¥45.0 | +4 | +9.76% |
| Nov 18 (Wed) | ¥41.0 | −2 | −4.65% |
| Nov 17 (Tue) | ¥43.0 | −1 | −2.27% |
| Nov 16 (Mon) | ¥44.0 | −2 | −4.35% |
| Nov 13 (Fri) | ¥46.0 | +1 | +2.22% |
| Nov 12 (Thu) | ¥45.0 | +0 | +0.00% |
| Nov 11 (Wed) | ¥45.0 | +1 | +2.27% |
| Nov 10 (Tue) | ¥44.0 | +0 | +0.00% |
| Nov 9 (Mon) | ¥44.0 | +2 | +4.76% |
| Nov 6 (Fri) | ¥42.0 | −3 | −6.67% |
If you had invested ¥100,000 3 months ago, it would be worth ¥56,250 today (−43.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −9.0%, while this stock moved −43.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 19 (Thu) | ¥45.0 | +4 | +9.76% |
| Nov 18 (Wed) | ¥41.0 | −2 | −4.65% |
| Nov 17 (Tue) | ¥43.0 | −1 | −2.27% |
| Nov 16 (Mon) | ¥44.0 | −2 | −4.35% |
| Nov 13 (Fri) | ¥46.0 | +1 | +2.22% |
| Nov 12 (Thu) | ¥45.0 | +0 | +0.00% |
| Nov 11 (Wed) | ¥45.0 | +1 | +2.27% |
| Nov 10 (Tue) | ¥44.0 | +0 | +0.00% |
| Nov 9 (Mon) | ¥44.0 | +2 | +4.76% |
| Nov 6 (Fri) | ¥42.0 | −3 | −6.67% |
If you had invested ¥100,000 6 months ago, it would be worth ¥38,462 today (−61.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −1.8%, while this stock moved −61.5%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥45.0 | −8.2% |
| Oct 2026 | ¥49.0 | −29.0% |
| Sep 2026 | ¥69.0 | −6.8% |
| Aug 2026 | ¥74.0 | −5.1% |
| Jul 2026 | ¥78.0 | +2.6% |
| Jun 2026 | ¥76.0 | −30.3% |
| May 2026 | ¥109 | −27.3% |
If you had invested ¥100,000 1 year ago, it would be worth ¥44,554 today (−55.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +22.5%, while this stock moved −55.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥45.0 | −8.2% |
| Oct 2026 | ¥49.0 | −29.0% |
| Sep 2026 | ¥69.0 | −6.8% |
| Aug 2026 | ¥74.0 | −5.1% |
| Jul 2026 | ¥78.0 | +2.6% |
| Jun 2026 | ¥76.0 | −30.3% |
| May 2026 | ¥109 | −27.3% |
| Apr 2026 | ¥150 | +22.0% |
| Mar 2026 | ¥123 | −26.3% |
| Feb 2026 | ¥167 | +35.8% |
| Jan 2026 | ¥123 | +13.9% |
| Dec 2025 | ¥108 | +2.9% |
| Nov 2025 | ¥105 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥23,438 today (−76.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +53.1%, while this stock moved −76.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥45.0 | −58.3% |
| 2025 | ¥108 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2024). Please check the latest prices before trading.
Chordia Therapeutics Inc. (190A) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Chordia Therapeutics Inc. (190A)
Business overview
The company is a drug discovery venture conducting R&D aimed at bringing new anticancer drugs to market. Its main business is researching and developing first-in-class small-molecule drugs with new mechanisms of action in cancer, an area of high medical need. The company concentrates on management and research work such as searching for, evaluating and optimizing candidate compounds and running clinical trials, while outsourcing basic research, manufacturing of drug substances and products, and distribution and sales to external partners. It actively pursues joint research and licensing with universities, public institutions, pharmaceutical companies and others to create new drugs efficiently. Its basic partnering strategy is to negotiate rights to sell outside Japan once the results of Phase 2 trials, considered the least likely to succeed, are available and the likelihood of reaching the market has increased.
Summarized from the annual securities report (fiscal year ended August 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 1.81x | Below the sector median of 1.87x (No. 37 from the lowest) |
|---|---|---|
| Market cap | ¥3.5 bn | No. 68 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥167 | 2/27 |
|---|---|---|
| 52-week low | ¥41 | 11/18 |
| Current position | 3.2% | Where the low is 0% and the high is 100% (close on 11/19: ¥45) |
| Year to date | -58.3% | No. 75 of 77 in the sector (best first) |
| 1 year | -55.5% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 11/19 (No. 15) |
|---|---|---|
| Top 50 losers | 1 times | Latest: 10/1 (No. 36) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/19 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/05 13:00(訂正・数値データ訂正)「2026年8月期 決算短信〔日本基準〕(非連結)」の一部訂正について
- 11/02 15:30第12回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 10/23 10:00資本準備金の額の減少及び剰余金の処分に関するお知らせ
- 10/15 16:002026年8月期決算説明資料
- 10/15 15:302026年8月期 決算短信〔日本基準〕(非連結)
- 10/01 15:30第12回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 09/30 11:30「革新的医療技術研究開発推進事業(産官学共同型)グローバルタイプ(難病・希少疾病治療グローバル研究開発支援事業)」採択のお知らせ
- 09/24 17:30Rogocekib初期拡大コホートの症例登録完了に関するお知らせ
- 09/09 15:30第三者割当による行使価額修正条項付第12回新株予約権(停止指定条項付)の発行に係る払込完了に関するお知らせ
- 09/09 15:30第9回新株予約権(行使価額修正条項付)の取得及び消却の完了に関するお知らせ
Filings from the past 12 months (10).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Chordia Therapeutics Inc. board
More Japanese stocks in English
- Sumitomo Forestry Co.,Ltd.1911
- JAPAN FOUNDATION ENGINEERING CO.,LTD.1914
- TOMOE CORPORATION1921
- DAIWA HOUSE INDUSTRY CO.,LTD.1925
- RAITO KOGYO CO.,LTD.1926
- Sekisui House,Ltd.1928
- NITTOC CONSTRUCTION CO.,LTD.1929
- Integroup Inc.192A
- HOKURIKU ELECTRICAL CONSTRUCTION CO.,LTD.1930
- YURTEC CORPORATION1934
- NIPPON RIETEC CO.,LTD.1938
- YONDENKO CORPORATION1939